Mesenchymoangioblast-derived mesenchymal stem cells Completed Phase 1 Trials for Graft Versus Host Disease (cGvHD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02923375A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease